Ielasi L.; Stefanini B.; Conti F.; Tonnini M.; Tortora R.; Magini G.; Sacco R.; Pressiani T.; Trevisani F.; Foschi F.G.; Piscaglia F.; Granito A.; Tovoli F., Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy, «CURRENT ONCOLOGY», 2024, 31, pp. 547 - 557 [Scientific article]Open Access
Stefanini, B.; Manfredi, G. F.; D'Alessio, A.; Fulgenzi, C. A. M.; Awosika, N.; Celsa, C.; Pirisi, M.; Rigamonti, C.; Burlone, M.; Vincenzi, F.; Minisini, R.; Gennari, A.; Yip, V.; Slater, S.; El-Shakankery, K.; Jain, A.; Tovoli, F.; Piscaglia, F.; Spalding, D.; Pai, M.; Pinato, D. J., Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2024, 18, pp. 647 - 660 [Scientific article]Open Access
Tovoli F.; Stefanini B.; Mandrioli D.; Mattioli S.; Vornoli A.; Sgargi D.; Manservisi F.; Piscaglia F.; Curti S.; Bolondi L., Exploring occupational toxicant exposures in patients with metabolic dysfunction-associated steatotic liver disease: A prospective pilot study, «DIGESTIVE AND LIVER DISEASE», 2024, 56, pp. 1 - 8 [Scientific article]Open Access
Rimini, M.; Stefanini, B.; Tada, T.; Suda, G.; Shimose, S.; Kudo, M.; Finkelmeier, F.; Yoo, C.; Presa, J.; Amadeo, E.; Genovesi, V.; Degrandis, M. C.; Iavarone, M.; Marra, F.; Foschi, F.; Tamburini, E.; Rossari, F.; Vitiello, F.; Bartalini, L.; Solda, C.; Tovoli, F.; Vivaldi, C.; Lonardi, S.; Silletta, M.; Kumada, T.; Sakamoto, N.; Iwamoto, H.; Aoki, T.; Himmelsbach, V.; Montes, M.; Hiraoka, A.; Sho, T.; Niizeki, T.; Nishida, N.; Steup, C.; Hirooka, M.; Kariyama, K.; Tani, J.; Atsukawa, M.; Takaguchi, K.; Itobayashi, E.; Fukunishi, S.; Tsuji, K.; Ishikawa, T.; Tajiri, K.; Ochi, H.; Yasuda, S.; Toyoda, H.; Ogawa, C.; Nishimura, T.; Hatanaka, T.; Kakizaki, S.; Shimada, N.; Kawata, K.; Tada, F.; Ohama, H.; Nouso, K.; Morishita, A.; Tsutsui, A.; Nagano, T.; Itokawa, N.; Okubo, T.; Arai, T.; Imai, M.; Kosaka, H.; Naganuma, A.; Koizumi, Y.; Nakamura, S.; Kaibori, M.; Iijima, H.; Hiasa, Y.; Persano, M.; Camera, S.; Foti, S.; Aldrighetti, L.; Cascinu, S.; Casadei-Gardini, A.; Piscaglia, F., Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab, «LIVER INTERNATIONAL», 2024, 44, pp. 1108 - 1125 [Scientific article]
Sansone, Vito; Auteri, Giuseppe; Tovoli, Francesco; Mazzoni, Camilla; Paglia, Simona; Di Pietro, Christian; Vianelli, Nicola; Cavo, Michele; Palandri, Francesca; Piscaglia, Fabio, Liver and spleen shear-wave elastography in the diagnosis and severity staging of myeloproliferative diseases and myelofibrosis, «JOURNAL OF ULTRASOUND», 2024, 27, pp. 715 - 722 [Scientific article]
Melero, I.; Yau, T.; Kang, Y.-K.; Kim, T.-Y.; Santoro, A.; Sangro, B.; Kudo, M.; Hou, M.-M.; Matilla, A.; Tovoli, F.; Knox, J.; He, A.R.; El-Rayes, B.; Acosta-Rivera, M.; Lim, H.Y.; Soleymani, S.; Yao, J.; Neely, J.; Tschaika, M.; Hsu, C.; El-Khoueiry, A.B., Nivolumab plus ipilimumab combination therapy in patients with advanced hepatocellular carcinoma previously treated with sorafenib: 5-year results from CheckMate 040, «ANNALS OF ONCOLOGY», 2024, 35, pp. 537 - 548 [Scientific article]Open Access
Stefanini, Bernardo; Tovoli, Francesco; Trevisani, Franco; Marseglia, Mariarosaria; Di Costanzo, Giovan Giuseppe; Cabibbo, Giuseppe; Sacco, Rodolfo; Pellizzaro, Filippo; Pressiani, Tiziana; Chen, Rusi; Ponziani, Francesca Romana; Foschi, Francesco Giuseppe; Magini, Giulia; Granito, Alessandro; Piscaglia, Fabio, Prediction of cardiovascular risk in patients with hepatocellular carcinoma receiving anti-angiogenic drugs: lessons from sorafenib, «INTERNAL AND EMERGENCY MEDICINE», 2024, 19, pp. 1151 - 1160 [Scientific article]Open Access
Monti, Federico; Perazza, Federica; Leoni, Laura; Stefanini, Bernardo; Ferri, Silvia; Tovoli, Francesco; Zavatta, Guido; Piscaglia, Fabio; Petroni, Maria Letizia; Ravaioli, Federico, RANK-RANKL-OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2024, 25, Article number: 9193 , pp. 1 - 15 [Scientific article]Open Access
Stefanini, Bernardo; Ielasi, Luca; Casadei-Gardini, Andrea; Piscopo, Michele; Tortora, Raffaella; Lani, Lorenzo; Pressiani, Tiziana; Sansone, Vito; Sacco, Rodolfo; Magini, Giulia; Renzulli, Matteo; Foschi, Francesco Giuseppe; Piscaglia, Fabio; Tovoli, Francesco; Granito, Alessandro, Repeated Previous Transarterial Treatments Negatively Affect Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib, «GASTROENTEROLOGY INSIGHTS», 2024, 15, pp. 519 - 529 [Scientific article]Open Access
Tovoli, Francesco; Pallotta, Dante Pio; Vivaldi, Caterina; Campani, Claudia; Federico, Piera; Palloni, Andrea; Dalbeni, Andrea; Soldà, Caterina; Lani, Lorenzo; Svegliati-Baroni, Gianluca; Garajova, Ingrid; Ielasi, Luca; De Lorenzo, Stefania; Granito, Alessandro; Stefanini, Bernardo; Masi, Gianluca; Marra, Fabio; Lonardi, Sara; Brandi, Giovanni; Bruno, Daniele; Auriemma, Alessandra; Schiadà, Laura; Chen, Rusi; Piscaglia, Fabio, Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma, «DIGESTIVE AND LIVER DISEASE», 2024, 56, pp. 2079 - 2084 [Scientific article]Open Access
Ielasi, Luca; Stefanini, Bernardo; Piscaglia, Fabio; Granito, Alessandro; Tovoli, Francesco, A Case of Advanced Hepatocellular Carcinoma with Bone Metastases Managed with Tyrosine Kinase Inhibitors and Aggressive Palliative Radiation Therapy: Role of Combination Therapy for Extending Survival, «GASTROENTEROLOGY INSIGHTS», 2023, 14, pp. 38 - 44 [Scientific article]Open Access
Casadei-Gardini, Andrea; Rimini, Margherita; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Rimassa, Lorenza; Presa, José; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Tovoli, Francesco; Kumada, Takashi; Sakamoto, Naoya; Iwamoto, Hideki; Aoki, Tomoko; Chon, Hong Jae; Himmelsbach, Vera; Pressiani, Tiziana; Montes, Margarida; Vivaldi, Caterina; Soldà, Caterina; Piscaglia, Fabio; Hiraoka, Atsushi; Sho, Takuya; Niizeki, Takashi; Nishida, Naoshi; Steup, Christoph; Iavarone, Massimo; Di Costanzo, Giovanni; Marra, Fabio; Scartozzi, Mario; Tamburini, Emiliano; Cabibbo, Giuseppe; Foschi, Francesco Giuseppe; Silletta, Marianna; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shima, Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population, «EUROPEAN JOURNAL OF CANCER», 2023, 180, pp. 9 - 20 [Scientific article]
Garajova I.; Gelsomino F.; Salati M.; Leonardi F.; De Lorenzo S.; Granito A.; Tovoli F., Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis, «CURRENT ONCOLOGY», 2023, 30, pp. 2613 - 2624 [Scientific article]Open Access
Brandi N.; Spinelli D.; Granito A.; Tovoli F.; Piscaglia F.; Golfieri R.; Renzulli M., COVID-19: Has the Liver Been Spared?, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2023, 24, Article number: 1091 , pp. 1 - 25 [Scientific article]Open Access
Chen R.; Ielasi L.; di Carlo A.; Tovoli F., Donafenib in hepatocellular carcinoma, «DRUGS OF TODAY», 2023, 59, pp. 83 - 90 [Scientific article]
